Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-25

FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approves Apotex Corp.'s supplemental application for diltiazem hydrochloride (generic) under an abbreviated new drug application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diltiazem hydrochloride (Diltiazem hydrochloride)

Snippet

SUPPL AP for DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE)